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Abstract
Background: Previous research on informed consent for research in psychiatric patients has
centered on disorders that affect comprehension and appreciation of risks. Little has been written
about consent to research in those subjects with Borderline Personality Disorder, a prevalent and
disabling condition.
Discussion: Despite apparently intact cognition and comprehension of risks, a borderline subject
may deliberately choose self-harm in order to fulfill abnormal psychological needs, or due to
suicidality. Alternatively, such a subject may refuse enrollment due to transference or the desire to
harm him or herself. Such phenomena could be precipitated or prevented by the interpersonal
dynamics of the informed consent encounter.
Summary: Caution should be exercised in obtaining informed consent for research from subjects
with Borderline Personality Disorder. A literature review and recommendations for future
research are discussed.
Background
Decision-making capacity in psychiatric patients has been
the topic of past research [1]. However, psychiatric disor-
ders considered in such research are most often the psy-
chotic and cognitive disorders [2]. This makes sense, as
informed consent is traditionally thought to hinge upon
comprehension [3].  However, such a viewpoint presup-
poses a subject that, understanding relative risks and ben-
efits of a proposed action, will usually act in a way that
maximizes benefit and minimizes harm to the self. Any
deviation from this self-preserving pattern of behavior in
the potential research subject is usually thought to result
from altruism or such obviously coercive circumstances as
financial reward, lack of other access to care, the percep-
tion that health care will be withdrawn without participa-
tion, etc.
However, what about people that persistently and inten-
tionally harm themselves? A large subpopulation of psy-
chiatric patients suffer pathology which centers around a
lifelong tendency to make what appear to others to be bad
decisions. They may persistently seek out victim roles and
manipulate others to harm them. They may make
repeated suicide attempts, or compulsively cut them-
selves. Can it be considered ethical to draw blood from
someone who consented because she has a psychological
need to see herself bleed?  Borderline personality disorder
(BPD) is a prevalent, chronic, disabling, and treatment-
resistant condition. It affects approximately 2% of com-
munity dwellers and 20% of psychiatric inpatients [4].
Although randomized clinical trials of both psychothera-
peutic and psychopharmacologic treatments for BPD are
relatively common [4,5], a literature search on consent
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issues with BPD subjects reveals little research. Border-
lines also likely have poorer general health (a 6.4% rate of
BPD has been measured in a primary care population [6])
than the general population and will likely be recruited
into non-psychiatric studies, in which the investigators
may be unaware of their psychiatric pathology and the
issues involved. Although little has been written on issues
of research informed consent in borderline personality
disorder, I would argue that caution must be exercised in
assessing a borderline subject's ability to consent based
solely on comprehension of a study.
DSM-IV-TR diagnostic criteria for borderline personality
disorder stipulates that a patient display five of the follow-
ing nine features [7]:
1) frantic efforts to avoid real or imagined abandonment
2) a pattern of unstable and intense interpersonal rela-
tionships characterized by alternating between extremes
of idealization and devaluation
3) identity disturbance: markedly and persistently unsta-
ble self-image or sense of self
4) impulsivity in at least two areas that are potentially self-
damaging (e.g., spending, sex, substance abuse, reckless
driving, binge eating)
5) recurrent suicidal behavior, gestures, or threats, or self-
mutilating behavior
6) affective instability due to a marked reactivity of mood
7) chronic feelings of emptiness
8) inappropriate, intense anger or difficulty controlling
anger
9) transient, stress-related paranoid ideation or severe dis-
sociative symptoms
Common clinical features include frequent intense mood
swings, the inability to be alone nor to tolerate intimacy,
extreme dependency on others alternating with sudden
hostility, perceiving others as all good or all bad ("split-
ting"), chronic self-mutilation (often described as reliev-
ing emotional pain), and chronic suicidality. BPD is
frequently comorbid with substance abuse, depression,
anxiety, and eating disorders [8]. Any of these symptoms
could have implications for the informed consent process.
Discussion
The Belmont Report, the Nurembug Code, and the Decla-
ration of Helsinki all discuss the need for informed, vol-
untary consent from research subjects.  Possible issues
concerning the validity of informed consent in borderline
subjects center on the voluntariness of consent. Most bor-
derline patients, except if in a brief psychotic episode
when under severe stress, have normal cognitive function,
and will be able to comprehend and speak about the risks
and benefits of a study.
However, long-term health benefits or more abstract serv-
ice to society may not be as important to them as their
immediate psychological needs. Such needs may include
recapitulations of childhood abuse. For example, they
may involve a need to feel the study doctor is hurting
them or putting them in danger, and the subject may con-
sent to research in order to gain this position. BPD sub-
jects may have an immediate need to use the idealizing
side of the splitting defense; they may feel special because
they were selected for the study, and consent in order to
have more contact with the idealized doctor. Alterna-
tively, a borderline subject's actions may be motivated by
the abrupt devaluing tendency seen in their interpersonal
relationships: they may refuse to consent to a study that
could significantly benefit them based on unwarranted
anger toward the study staff. Finally, a borderline patient
may enter a study because she is suicidal, and hopes he or
she will die as part of the study.
Just as financial compensation may be in fact coercive to
some populations, these perceived benefits may in fact be
considered coercive for the borderline subject. The Freud-
ian concept of psychic determinism, which states that all
decisions are predestined by the interplay of intrapsychic
forces and therefore always necessarily subjective, might
in the extreme lead us to conclude that no consent is
purely voluntary. However, the concern that decisions are
not made based on logical consideration but rather on
psychological needs applies especially to borderline sub-
jects, for whom rational decision making is a clear weak-
ness.
Carl Elliott raised somewhat similar concerns regarding
informed consent for research with the severely depressed
[3]. Recognizing that in an extremely depressed state, a
subject may understand risks but not be concerned about
them, Elliott called for an appreciation of emotional and
motivational factors in the informed consent process. He
argued that consent might not be considered valid for a
depressed subject because of state-dependent changes in
priorities which wouldn't coincide with the subject's
"usual" personality. This argument flounders when we
consider the borderline subject, whose most prominent
personality trait is instability. Elliott also contends that
consent may be considered invalid if it is not motivated in
part by self-interest. This thesis applies better to BPD sub-
jects, who may enroll hoping to be harmed. It does not,BMC Medical Ethics 2007, 8:4 http://www.biomedcentral.com/1472-6939/8/4
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however, completely acknowledge that BPD patients have
wants and needs that they try to meet; these are just wants
and needs that are strange to those without BPD.
In light of these concerns, should borderlines be excluded
from research studies? Obviously not. First of all, this
would not be practically possible with current standards.
There are many more patients with BPD than those who
have it documented in their medical records. Even if a
study involves formal psychiatric evaluation, practitioners
often mistake BPD for other conditions (for example,
chronic major depression or bipolar disorder) [6]. This
may be due to lack of long-term knowledge of the subject
and his or her persistent coping mechanisms. Alterna-
tively, practitioners hesitate to assign a diagnosis that
many consider pejorative and untreatable.
Even if borderlines could be more reliably identified prior
to informed consent, they cannot be ethically excluded
from research because this condition desperately needs
better treatments [4,5]. While there is some evidence of
efficacy for antidepressants, antipsychotics, Dialectical
Behavior Therapy, and other psychotherapies, recent sys-
tematic reviews on both psychopharmacology and psy-
chosocial interventions for BPD called for more research.
What specialized treatments there are, are not widely
available, and many borderlines are prescribed somewhat
haphazard polypharmacy regimens with little empiric
basis.
If borderline subjects' chronic problems with transfer-
ence, splitting, impulsivity, paranoia, self-injury, and sui-
cidality complicate the informed consent process, but if
this process is none the less imperative, how are we to pro-
ceed?  As very little research has been done in this area,
hard guidelines for informed consent are premature. But
future research should seek to address such questions
about informed consent. It may be that borderlines
should undergo the consent process with people who are
used to working with this disorder. This could include
experienced mental health nursing staff, or, more likely,
someone with psychotherapy training. Experience and
training in psychotherapy enables one to monitor trans-
ference and counter-transference throughout the encoun-
ter with the borderline subject, lending insight into the
subject's current motivational state and helping keep her
or his affect from spinning out of control. These skills may
also minimize unconscious acting out by the study team.
For example, someone inexperienced with borderlines
may not recognize that he or she is being idealized and
may think "we really will be able to do great things for this
person; I must get her into the trial." Or an inexperienced
clinician may encounter a hostile subject and uncon-
sciously adjust entry criteria such that she does not qual-
ify, or over-emphasize risks in a way that leads her to
decline enrollment. Future studies should aim to deter-
mine whether psychotherapeutic knowledge and experi-
ence affects the informed consent process with BPD
subjects. Experiments could potentially involve having
researchers with varying levels of psychotherapeutic expe-
rience consent the same subjects for similar studies, com-
paring the resultant interpersonal interactions.
Another relevant question is whether the person obtain-
ing consent can ethically be the subject's therapist or psy-
chiatrist. One of the criteria for the diagnosis of BPD is
"frantic efforts to avoid real or imagined abandonment."
Whatever the consent form says about lack of consent not
affecting provision of medical care, borderlines live in a
world where desertion is always seconds away. Thus, they
may be easily coerced to participate based on the fear of
loss of love; they also might refuse a trial that could bene-
fit them, in order to test the loyalty of those seeking their
participation. This question could be tested by comparing
a consent experience using a BPD's own therapist with
another using an unknown researcher.
In addition, given the chronic impulsivity BPD subjects
display, it may be that informed consent processes that
take place over more than one visit could increase the
validity of the consent (as well as help retention rates).
Letting the subject consider the study away from the inter-
personal context of the clinic may help him to be more
objective about his desires and less interpersonally reac-
tive.  Multiple consents could be fairly easily added to a
research protocol with follow-up subject satisfaction sur-
veys and comparisons of retention rates.
Whether proxy decision-makers apply to this situation is
another question.  Severely-ill borderlines may have
court-appointed guardians that will be enlisted in the con-
sent process; however, in some cases in which the patient
is his or her own guardian but seems incapable of making
a rational decision, surrogate decision-makers could be
considered.
Summary
Clinical research on borderline personality disorder is
alarmingly underdeveloped considering the prevalence
and costliness of this disease [4,5].  This problem is likely
in part related to practical difficulties involved in safely
recruiting and treating borderline research subjects.
Research in this area must be done. Nonetheless, due to
the questions of motivation and voluntariness, caution
must be exercised in gaining informed consent from bor-
derline subjects.
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